aTYR PHARMA INC — Director's Dealing 2020

Jun 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2020-06-19

Reporting Person: Shukla Sanjay (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-19	Common Stock	P	6000	$4.27	Acquired	7291	Direct

Footnotes

F1: Represents weighted average price for the shares. The shares were purchased at price ranging from $4.21 to $4.30 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.